Invited Speaker: Advances in Veterinary Extended Release Injectables Formed in situ and a Case Study

Category
Novel Development in Formulation, Analytical Chemistry, and Processing in Animal Health and Preclinical Sciences
Year
2014
Authors
Susan M. Cady
Institutions
Merial Limited (A Sanofi Company), 631 Route 1 South, North Brunswick, NJ 08902, USA
Summary

The animal health industry maintains a strong interest in controlled release parenteral formulations and has seen pioneering innovation in drug delivery technology for both production and companion animals.1 Easy, ready-to-use products are preferred in the market place. This presentation will focus on an overview of sustained release injectables formed in situ and their use as veterinary parenteral products.2, 3 SUCROMATE™, BUPRENORPHINE SRTM, and MELOXICAM SRTM and LONGRANGE® (eprinomectin), an extended release prescription injectable parasiticide for cattle, will be discussed.